Caught in the act: Scientists observe infections by cancer-causing retroviruses in koalas as they occur
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Jun-2026 16:15 ET (21-Jun-2026 20:15 GMT/UTC)
An international team of scientists analysed the ongoing colonization by two retroviruses of the germline of koalas and resulting deaths from cancer in multi-generational pedigrees of over 100 koalas in US and European Zoos. In the journal Nature Communications, they describe the genome sequencing of the koalas and their analysis of integration in or near genes involved in cancer, new germline integrations within a single generation, and deaths from cancer caused by the retroviral integration. Based on this work, the scientists calculated genetic risk scores (GRS) that can help guide koala breeding programs and thereby benefit koala conservation efforts.
The FXYD proteins (FXYD domain-containing ion transport regulators) are a family of seven distinct proteins that play crucial roles in regulating Na+/K+-ATPase (NKA) activity. Each of these proteins is characterized by a conserved 35-amino-acid FXYD domain, essential for their functions, and exhibits tissue-specific expression, contributing to diverse roles in various tissues.
Research over the years has highlighted the role of the FXYD proteins in regulating numerous physiological processes, including ion transport, neuronal activity, cell adhesion, and migration; conversely, their altered expression has been implicated in the progression of various diseases, such as cancer, neurological, cardiovascular, and renal diseases, and others. Understanding the FXYD proteins and their underlying regulatory mechanisms may therefore aid in identifying novel therapeutic targets.
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of two well-studied classes of drugs – ERBB inhibitors and Aurora kinase inhibitors – is significantly more effective against KRAS-mutated lung adenocarcinomas than existing therapies. The research, currently published in the journal npj Precision Oncology, opens up a new and promising path for patients for whom there are currently only limited treatment options.
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
Researchers used Google DeepMind’s AlphaFold2 and ProteinMPNN to speed development of antibody-based probes that can be used to see key functions and chemical changes inside living cells as they happen. This AI-driven method is significantly faster than previous manual testing and development approaches, allowing the CSU team to rapidly create and test 19 new potential probes. The work enables continuous imaging of living cells, which may help researchers better understand errors in genetic expression that can lead to cancer and other disorders.
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and poor patient recruitment.
By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative breast cancer, the most aggressive and difficult to treat subtype of the disease.
A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the University of Michigan, could help doctors discover which treatment strategies are most likely to be effective against individual cases of glioma. The team verified the accuracy of the model by comparing it against human patient data and running mouse experiments.